On February 8, the PMDA held the “PMDA-ATC COVID-19 related In Vitro diagnostics (IVDs) Webinar for the Medical Device Authority (MDA), the Ministry of Health Malaysia.”
The webinar reviewed COVID-19 related IVDs. The PMDA shared information on the Japanese regulatory system and PMDA’s experiences with 66 MDA staff members engaged in medical devices regulation including their premarket control.
The PMDA continues to promote collaboration with MDA through training seminars and other activities.
See attached program[71.7 KB].
Back
Back
-
Regulations & Services of PMDAInformation about Approved Products in JapanSafety InformationAdvanced Efforts
-
Information for approved products in JapanSafety information
-
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnosticsInformation for approved products in JapanRegulatory science
-
Regulations and services of PMDAInformation for approved products in JapanProcedures in JapanAdvanced efforts
Back
-
Regulations and Services of PMDAInformation for apporoved products in JapanSafety informationProcedures in Japan
-
Regulations and Services of PMDAInformation for apporoved products in JapanSafety informationProcedures in Japan
-
Reviews and Related ServicesRegulatory ProceduresPost-marketing Safety Measures
-
Reviews and Related ServicesPost-marketing Safety Measures
- Home
- Events and Symposia
- Report of the PMDA-ATC COVID-19 related IVDs Webinar for MDA, Malaysia
Events and Symposia